6/27/2014 7:31:49 AM
EWING, N.J., June 27, 2014 (GLOBE NEWSWIRE) -- Celator Pharmaceuticals, Inc. (Nasdaq:CPXX), a pharmaceutical company developing new and more effective therapies to treat cancer, announced that effective at the close of the U.S. markets today the Company will be added to the Russell MicroCap Index® as part of Russell Investments' annual reconstitution of its comprehensive set of U.S. and global equity indexes.
Help employers find you! Check out all the jobs and post your resume.
comments powered by